
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is well-positioned in the healthcare industry, with a strong track record and competitive advantages. Its focus on value-added services, global distribution, and specialty products make it a key player in the market. With a solid financial position and promising growth opportunities, the company has the potential to continue delivering strong results and outperforming its competitors.
Bears say
Henry Schein is a company with potential for future growth, evident from its recent upgrade to a Buy rating. Its spin-off Envista also displays potential with strong earnings in the first quarter of 2026. However, HSIC faces competition in the dental market and relies on long-term contracts and third-party suppliers, which could be disrupted. Additionally, analysts have mixed recommendations for HSIC and the stability of the dental industry could impact HSIC's growth.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares